Company intelligence / Profile preview
ProDa BioTech
Marietta, Georgia, United Statesventureradar.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
ProDa BioTech’s lead candidate, ProAgio, is a recombinant protein that targets integrin αvβ₃ on cancer-associated fibroblasts and angiogenic endothelial cells. It has shown preclinical efficacy in animal models of pancreatic and triple-negative breast cancers by disrupting the tumor stroma barrier, improving drug delivery, and reducing side effects. Clinical development is ongoing with Phase II trials in TNBC and early-stage trials/plans for other solid tumors including pancreatic, liver, lung, prostate, and colorectal cancers. The company has received NIH/NCI funding to advance its programs into clinical studies[1][5][6][7].
- Therapeutic areas
- Oncology
- Modalities
- Recombinant protein therapeutics
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
No major pharma partnerships publicly disclosed as of May 2025. The company seeks outlicensing partners/investors at industry conferences.
Beyond the preview
Go deeper on ProDa BioTech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProDa BioTech.